SI-BONE Q2 2026 Revenue Up 15%, Adjusted EBITDA Turns Positive
SI-BONE reported 15.2% second-quarter revenue growth to $56.0 million, achieved positive adjusted EBITDA, and raised its 2026 outlook due to strong demand and improved reimbursement.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day